NCT07364071 2026-01-27
SENTRY
University of California, San Diego
Phase 2 Not yet recruiting
Clinical Trials
10 trialsNCT07268339 2025-12-05
TRAIN
The Christie NHS Foundation Trust
Phase 3 Not yet recruiting
NCT07100184 2025-08-03
RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients
Peking University First Hospital
Phase 2 Not yet recruiting
NCT07053735 2025-07-08
An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer
Peking University First Hospital
Phase 1 Not yet recruiting
NCT07043608 2025-07-02
ZAMBONI
University of California, San Francisco
Phase 2 Not yet recruiting
NCT06855589 2025-03-04
PCS-XII
Charles LeMoyne Hospital
Phase 3 Not yet recruiting
NCT06686381 2025-02-05
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
American University of Beirut Medical Center
Phase 2 Not yet recruiting
NCT06310369 2024-07-22
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Not yet recruiting
NCT04176081 2024-01-24
SChLAP/IDC
University Health Network, Toronto
Phase 2 Not yet recruiting
NCT05912205 2023-06-22
Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Not yet recruiting